icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study
 
 
  Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
 
S. Traussnigg, J. M. Schattenberg, M. Demir, J. Wiegand, A. Geier, G. Teuber, W. P. Hofmann, A. E. Kremer, F. Spreda, J. Kluwe, J. Petersen, T. Boettler, E. Halilbasic, R. Greinwald, M. Proels, M. P. Manns, P. Fickert, M. Trauner

1113171

1113172

1113173

1113174

1113175

1113176

1113177

1113178

1113179